These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33897418)

  • 21. Optimization of Vancomycin Initial Dosing Regimen in Neonates Using an Externally Evaluated Population Pharmacokinetic Model.
    Blouin M; Métras MÉ; El Hassani M; Yaliniz A; Marsot A
    Ther Drug Monit; 2024 Jun; ():. PubMed ID: 38857472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External evaluation and systematic review of population pharmacokinetic models for high-dose methotrexate in cancer patients.
    Yang Y; Wang C; Chen Y; Wang X; Jiao Z; Wang Z
    Eur J Pharm Sci; 2023 Jul; 186():106416. PubMed ID: 37119861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.
    Zhang R; Chen M; Liu TT; Lu JJ; Lv CL
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):135-149. PubMed ID: 31541402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates.
    Matcha S; Dillibatcha J; Raju AP; Chaudhari BB; Moorkoth S; Lewis LE; Mallayasamy S
    Paediatr Drugs; 2023 May; 25(3):365-375. PubMed ID: 36943583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External Validation of a Vancomycin Population Pharmacokinetic Model and Developing a New Dosage Regimen in Neonates.
    Lim CP; Tseng SH; Neoh CCC; Chen Q; Poon WB
    Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):687-697. PubMed ID: 35804218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models.
    Dai HR; Liu Y; Guo HL; Lu KY; Hu YH; Zhang YY; Wang J; Ding XS; Jiao Z; Cheng R; Chen F
    Eur J Pharm Biopharm; 2024 Nov; 204():114484. PubMed ID: 39251033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation.
    Huang H; Liu M; Ren J; Hu J; Lin S; Li D; Huang W; Chen S; Yang T; Wu X
    J Clin Pharmacol; 2022 May; 62(5):609-619. PubMed ID: 34695225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External validation of vancomycin population pharmacokinetic models in ten cohorts of infected Chinese patients.
    Zhou Y; Long E; Shi T; Wang Z; Zhao J; Liu H; Lin Y; Jiang M; Lao H; Ge W; Cui Y
    J Glob Antimicrob Resist; 2022 Sep; 30():163-172. PubMed ID: 35640870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates.
    Alrahahleh D; Thoma Y; Van Daele R; Nguyen T; Halena S; Luig M; Stocker S; Kim HY; Alffenaar JW
    Clin Pharmacokinet; 2024 Mar; 63(3):367-380. PubMed ID: 38416322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
    Marsot A; Gallais F; Galambrun C; Coze C; Blin O; Andre N; Guilhaumou R
    Paediatr Drugs; 2018 Aug; 20(4):375-381. PubMed ID: 29736878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian forecasting of serum vancomycin concentrations in neonates and infants.
    Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
    Ther Drug Monit; 1995 Jun; 17(3):239-46. PubMed ID: 7624919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.
    Heus A; Uster DW; Grootaert V; Vermeulen N; Somers A; In't Veld DH; Wicha SG; De Cock PA
    Int J Antimicrob Agents; 2022 May; 59(5):106579. PubMed ID: 35341931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin: Predictive Performance of a Population Pharmacokinetic Model and Optimal Dose in Neonates and Young Infants.
    Marsot A; Vialet R; Boulamery A; Bruguerolle B; Simon N
    Clin Pharmacol Drug Dev; 2012 Oct; 1(4):144-51. PubMed ID: 27121456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.
    Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT
    JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients.
    Yang N; Wang J; Xie Y; Ding J; Wu C; Liu J; Pei Q
    Front Pharmacol; 2022; 13():838205. PubMed ID: 35662716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards Precision Dosing of Clozapine in Schizophrenia: External Evaluation of Population Pharmacokinetic Models and Bayesian Forecasting.
    Lereclus A; Korchia T; Riff C; Dayan F; Blin O; Benito S; Guilhaumou R
    Ther Drug Monit; 2022 Oct; 44(5):674-682. PubMed ID: 35385439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically Based Pharmacokinetic Modeling of Vancomycin and its Comparison with Population Pharmacokinetic Model in Neonates.
    Cao A; Li Q; Han M; Liu Q; Liang H; Tan L; Guan Y
    J Clin Pharmacol; 2024 Sep; ():. PubMed ID: 39223982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin: a review of population pharmacokinetic analyses.
    Marsot A; Boulamery A; Bruguerolle B; Simon N
    Clin Pharmacokinet; 2012 Jan; 51(1):1-13. PubMed ID: 22149255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.